Andrew Alan Moeser

Andrew * is a versatile litigator. His practice is primarily focused on intellectual property litigation, but he is equally comfortable handling a judicial review or a contaminated property dispute. When it comes to complex issues, he gets it § whether it’s a scientific study or a legal strategy. Possessing a master’s degree in biology and having worked as a coordinator of a phase III clinical trial, Andrew is that combination of litigator and scientist that brings a deep understanding to the issues facing our clients. He makes the situation right ‡ by knowing the client’s business and drawing on his diverse litigation experience to provide the fitting solution to any problem. .

"Andrew has a brilliant legal mind. He is a strategic thinker and is able to formulate creative and practical solutions to overcome the toughest challenges." — Chambers Canada

A versatile litigator, he also has significant experience in commercial litigation relating to environmental contamination, and in judicial reviews in regulated industries such as pharmaceuticals, mining, and renewable energy.

Andrew has represented clients before all levels of court in Ontario, the Federal Court, the Federal Court of Appeal, and the Alberta Court of Appeal. He has acted pro hac vice in proceedings in the United States and has extensive experience working within international teams on large cross-border disputes.

Andrew is also an Adjunct Professor at the University of Toronto Faculty of Law, where he supervises a legal clinic that assists the Structural Genomics Consortium, a not-for-profit public-private partnership that engages in precompetitive basic science research to facilitate and enable the discovery of new medicines.

Counsel to Gilead Sciences, Inc. and Gilead Sciences Canada, Inc., global pharmaceutical and biotechnology companies, in defending an NOC action in the Federal Court involving Canadian Patent Nos. 2,845,553 and 2,990,210.